4D Molecular Therapeutics (FDMT) Property, Plant & Equipment (Net) (2019 - 2026)

4D Molecular Therapeutics (FDMT) Property, Plant & Equipment (Net) (2019 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Property, Plant & Equipment (Net) (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	642,333.36
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	5.32 Mn
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	1.64 Bn
4	NuCana	279.75 Bn	279.75 Bn	-	875,249.36
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	1.61 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	5.27 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	1.96 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	31.48 Mn
10	4D Molecular Therapeutics	706.51 Mn	315.62 Mn	-	13.59 Mn

Download Data